---
figid: PMC270001__1477-7827-1-66-2
figlink: /pmc/articles/PMC270001/figure/F2/
number: F2
caption: Hypothetical Model of Chemoresistance in Human Ovarian Cancer Cells. In a
  chemosensitive ovarian cancer cell (A), cisplatin increases p53 content, leading
  to upregulation of proteins promoting cell cycle arrest, such as p21, and of pro-apoptotic
  proteins such as Bax and Fas. This activates both the intrinsic (mitochondrial)
  and extrinsic (death-receptor) apoptotic pathways, the overall result of which is
  the activation of the execution caspase-3 (and -7, not shown). In these cells, cell
  survival mediators such as Xiap, Akt, and Flip (shown in red) are downregulated
  or are in their inactive state. Prohibitin may also play a role in inhibiting cell
  cycle progression through the Rb-E2F pathway by binding to Rb. Conversely, in a
  chemoresistant cell (B), increased p53 ubiquitination by MDM2 results in the maintenance
  of low levels of p53, despite the presence of cisplatin. Moreover, cisplatin fails
  to downregulate Xiap, thereby maintaining an active state of the PI3K/Akt pathway.
  In addition, binding of TNFR2 by TNFα leads to upregulation of FLIP through the
  NFκB pathway, thus inhibiting the pro-apoptotic actions of the cytokine through
  TNFR1. Overall, as a consequence of a failure to activate the caspase cascade in
  response to the chemotherapeutic agent, these cells have lost their capacity to
  undergo apoptosis, and thus became chemoresistant.
pmcid: PMC270001
papertitle: 'Chemoresistance in human ovarian cancer: the role of apoptotic regulators.'
reftext: Michael Fraser, et al. Reprod Biol Endocrinol. 2003;1:66-66.
pmc_ranked_result_index: '12778'
pathway_score: 0.9300241
filename: 1477-7827-1-66-2.jpg
figtitle: Chemoresistance in Human Ovarian Cancer Cells
year: '2003'
organisms: Homo sapiens
ndex: f1c09afc-df0a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC270001__1477-7827-1-66-2.html
  '@type': Dataset
  description: Hypothetical Model of Chemoresistance in Human Ovarian Cancer Cells.
    In a chemosensitive ovarian cancer cell (A), cisplatin increases p53 content,
    leading to upregulation of proteins promoting cell cycle arrest, such as p21,
    and of pro-apoptotic proteins such as Bax and Fas. This activates both the intrinsic
    (mitochondrial) and extrinsic (death-receptor) apoptotic pathways, the overall
    result of which is the activation of the execution caspase-3 (and -7, not shown).
    In these cells, cell survival mediators such as Xiap, Akt, and Flip (shown in
    red) are downregulated or are in their inactive state. Prohibitin may also play
    a role in inhibiting cell cycle progression through the Rb-E2F pathway by binding
    to Rb. Conversely, in a chemoresistant cell (B), increased p53 ubiquitination
    by MDM2 results in the maintenance of low levels of p53, despite the presence
    of cisplatin. Moreover, cisplatin fails to downregulate Xiap, thereby maintaining
    an active state of the PI3K/Akt pathway. In addition, binding of TNFR2 by TNFα
    leads to upregulation of FLIP through the NFκB pathway, thus inhibiting the pro-apoptotic
    actions of the cytokine through TNFR1. Overall, as a consequence of a failure
    to activate the caspase cascade in response to the chemotherapeutic agent, these
    cells have lost their capacity to undergo apoptosis, and thus became chemoresistant.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP7
  - CASP9
  - RELB
  - CASP10
  - MDM2
  - CASP8
  - BAX
  - CDK6
  - NFKB1
  - NFKB2
  - FAS
  - CASP6
  - TP53
  - CFLAR
  - AKT3
  - TNFRSF1B
  - CASP12
  - CDK4
  - E2F2
  - PTK2
  - CASP5
  - AKT1
  - E2F8
  - E2F7
  - TNFRSF1A
  - E2F3
  - AKT2
  - E2F5
  - E2F1
  - XIAP
  - E2F4
  - CASP2
  - E2F6
  - RELA
  - CASP1
  - CASP14
  - CASP3
  - CASP4
  - REL
  - Cisplatin
  - Cancer
genes:
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: cdk4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: FLIP
  symbol: FLIP
  source: hgnc_alias_symbol
  hgnc_symbol: CFLAR
  entrez: '8837'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TNFR2
  symbol: TNF-R-II
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1B
  entrez: '7133'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: cdk4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: TNFR1
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase-
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC270001__F2
redirect_from: /figures/PMC270001__F2
figtype: Figure
---
